Form D · Other Health Care
Jade Healthcare, Inc.
New York, NY · CIK 0001912851
Offering snapshot reported Feb 25, 2022 · SEC filing
- Reported sold
- $8.82M Offering amount: $10M
- Investors reported
- 26 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 10, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 25, 2022 | Initial | $8,815,763 | No comparison | 26 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-435106
Source: Form D, filed Feb 25, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Lori Evans Bernstein | Director, Executive |
| Alyssa Jaffe | Director |
| Lee Shaprio | Director |
| Joshua Trauber | Executive |
| Michael Yang | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
1136 5 Th Avenue Apartment 7 B
New York, NY, 10128
New York, NY, 10128